Aspire Biopharma Holdin-CW27ASBPWPreferred / convertible
13F holders, Q4 2025 (December 31)29holders
2new positions
2sold out
1famous investor
$0.04avg. 13F price*
At the end of Q4 2025, 29 institutions reported holding Aspire Biopharma Holdin-CW27 (ASBPW) in their 13F filings, unchanged from Q3 2025. 2 opened new positions and 2 sold out. The largest holders were Mint Tower Capital Management B.V. ($132K), Saba Capital Management, L.P. ($19K) and Linden Advisors LP ($18K). One famous investor held it David E. Shaw ( of D. E. Shaw & Co.'s portfolio).
- Company
- Aspire Biopharma Holdin-CW27
- CUSIP
- 738920115
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2025 → Q4 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $3K |
| Exits | 2 | $6K |
All 13F filers, Q3 2025 → Q4 2025: 41,383 shares bought and 315,271 shares sold, net −273,888 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 29 holders
| Mint Tower Capital Management B.V. | — | No change | 25,000 | $132K |
| Saba Capital Management, L.P. | — | No change | 983,603 | $19K |
| Linden Advisors LP | — | No change | 899,999 | $18K |
| Adage Capital Partners Gp, L.L.C. | — | No change | 1,050,000 | $17K |
| Aristeia Capital, L.L.C. | — | No change | 681,516 | $13K |
| Sculptor Capital LP | — | No change | 500,000 | $10K |
| Toronto Dominion Bank | — | Reduce -0.1% | 516,445 | $8K |
| Verition Fund Management LLC | — | No change | 432,757 | $7K |
| Barclays PLC | — | No change | 350,000 | $6K |
| Clear Street Group Inc. | — | Reduce -24.4% | 330,764 | $5K |
| Antara Capital LP | — | No change | 207,693 | $3K |
| D. E. Shaw & Co. | — | No change | 199,999 | $3K |
| Wolverine Asset Management LLC | — | No change | 197,144 | $3K |
| Athos Capital Ltd | — | New | 21,383 | $3K |
| Context Capital Management, LLC | — | No change | 175,000 | $3K |
| Polar Asset Management Partners Inc. | — | No change | 138,536 | $3K |
| LMR Partners LLP | — | No change | 125,000 | $2K |
| Periscope Capital Inc. | — | No change | 124,924 | $2K |
| Whitebox Advisors LLC | — | No change | 118,750 | $2K |
| VR Advisory Services Ltd | — | No change | 99,692 | $2K |
| Limestone Investment Advisors LP | — | No change | 75,000 | $1K |
| Blue Owl Capital Holdings LP | — | No change | 50,000 | $1K |
| Picton Mahoney Asset Management | — | No change | 50,000 | $825 |
| Crossingbridge Advisors, LLC | — | No change | 49,846 | $822 |
| OMERS ADMINISTRATION Corp | — | No change | 25,000 | $412 |
| Beacon Pointe Advisors, LLC | — | New | 20,000 | $330 |
| Flow Traders U.S. LLC | — | Reduce -2.3% | 14,550 | $0 |
| Osaic Holdings, Inc. | — | No change | 50 | $0 |
| Investors Research Corp | — | No change | 10 | $0 |
"% of holder's portfolio" is ASBPW's weight in each manager's 13F, not the share of Aspire Biopharma Holdin-CW27 the manager owns.